UK Industry Skeptical Of Govt’s No-Deal Brexit Filing Expectations
18 Feb 2019
The BioIndustry Association’s latest Brexit webinar looked at issues such as companies’ drug filing strategies in a no-deal scenario as...
Related Stories Heart Rhythm Concerns Prompt EU-Wide Suspension For Fenspiride Cough Medicines Australia Considers Identifying Drugs Filed For Approval
FDA Launches Pilot To Gain Practical Experience With 'Established Conditions' In Quality Assessments
Organizations
Indications
-Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.